West Pharmaceutical Services, Inc.
WST Real Time Price USD$WST is featured in our Bill Gates strategy.
All StrategiesRecent trades of WST by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in WST holdings by institutional investors
Quarterly net insider trading by WST's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
WST Estimated quarterly lobbying spending
WST Revenue by Segment or Geography
New WST patent grants
-
Patent Title: Low-profile snap fit lid Aug. 08, 2023
-
Patent Title: Display screen or portion thereof with graphical user interface Dec. 06, 2022
-
Patent Title: Injection needle shield puller Apr. 12, 2022
-
Patent Title: Display screen or portion thereof with icon Jun. 01, 2021
-
Patent Title: Syringe housing May. 18, 2021
-
Patent Title: Syringe housing May. 18, 2021
-
Patent Title: Needle guard May. 18, 2021
-
Patent Title: Needle guard May. 11, 2021
-
Patent Title: Syringe adapter Jun. 02, 2020
-
Patent Title: Injector device Mar. 17, 2020
-
Patent Title: Injector device Mar. 17, 2020
-
Patent Title: Injector device Mar. 17, 2020
-
Patent Title: Injection assist device Jul. 23, 2019
-
Patent Title: Multi-part collar Jul. 02, 2019
-
Patent Title: Multi-part collar Jun. 11, 2019
-
Patent Title: Injection assist device May. 07, 2019
-
Patent Title: Injection assist device May. 07, 2019
-
Patent Title: Finger flange Apr. 09, 2019
-
Patent Title: Injection assist device Mar. 05, 2019
-
Patent Title: Container lid Feb. 26, 2019
-
Patent Title: Container lid Feb. 19, 2019
-
Patent Title: Container and lid Feb. 19, 2019
-
Patent Title: Injection assist device Jan. 15, 2019
-
Patent Title: Injection assist device Jan. 08, 2019
-
Patent Title: Medical container nest Jan. 01, 2019
-
Patent Title: Medical container nest Dec. 25, 2018
-
Patent Title: Medical container nest Dec. 11, 2018
-
Patent Title: Medical container nest Dec. 11, 2018
-
Patent Title: Finger flange Mar. 06, 2018
-
Patent Title: Low radial profile needle safety device Mar. 06, 2018
-
Patent Title: Injector device Jan. 16, 2018
-
Patent Title: Injector device Jan. 09, 2018
-
Patent Title: Injector device Jan. 02, 2018
-
Patent Title: Injector device Dec. 26, 2017
-
Patent Title: Injector device Dec. 26, 2017
-
Patent Title: Injector device Dec. 19, 2017
-
Patent Title: Injector device Dec. 19, 2017
-
Patent Title: Injector device Dec. 12, 2017
-
Patent Title: Injector device Dec. 12, 2017
-
Patent Title: Injector device Dec. 12, 2017
-
Patent Title: Injector device Dec. 12, 2017
-
Patent Title: Injector device Dec. 12, 2017
-
Patent Title: Injector device Dec. 05, 2017
-
Patent Title: Injector device Nov. 28, 2017
-
Patent Title: Adapter for a syringe Aug. 01, 2017
-
Patent Title: Finger flange Jun. 27, 2017
-
Patent Title: Tamper evident closure for containers Feb. 14, 2017
-
Patent Title: Needle shield for disposable syringe with annular ring Oct. 25, 2016
-
Patent Title: Hub for medical container Nov. 05, 2013
-
Patent Title: Syringe plunger rod Sep. 03, 2013
Federal grants, loans, and purchases
Estimated quarterly amount awarded to WST from public contracts
Recent insights relating to WST
Recent picks made for WST stock on CNBC
ETFs with the largest estimated holdings in WST
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $WST stock a Buy, Sell, or Hold?
- What is the price target for $WST stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $WST stock?
- Who owns the most shares of $WST stock?
- What funds own $WST stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view WST Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
- Address Exton, PA
- Market Cap 19.5 billion
- Employees 10,600
- Industrial Classification Surgical & Medical Instruments & Apparatus